Psychotropic agents

Pharmacokinetics in Drug Discovery and Development

Volumn , Issue , 2002, Pages 171-200

  Perry, Paul J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1642387945     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (16)

1. Dahl, S. G., Plasma level monitoring of antipsychotic drugs: clinical utility, Clin. Pharmacokinet., 11: 36-61, 1986.
2. Sramek, J. J., Potkin, S. T., and Hahn, R., Neuroleptic plasma concentrations and clinical response: in search of a therapeutic window, Drug Intell. Clin. Pharm., 22: 373-380, 1988.
3. Garver, D. L., Neuroleptic drug levels and antipsychotic effects: a difficult correlation; potential advantage of free (or derivative) versus total plasma levels, J. Clin. Psychopharmacol., 9: 277-281, 1989.
4. Balant-Gorgia, A. E., Blanat, L. P., and Andreoli, A., Pharmacokinetic optimization of the treatment of psychosis, Clin. Pharmacokinet., 25: 217-236, 1993.
5. Preskorn, S. H. and Burke, M. J., Fast GA, therapeutic drug monitoring, Psychiatr. Clin. North Am., 16: 611-645, 1993.
6. Goodman, L. S., Limbird L. E., and Milinoff, P. B., Eds., Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York, 1996.
7. Perry, P. J., Zeilmann, C., and Arndt, S., Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response, J. Clin. Psychopharmacol., 14: 230-240, 1994.
8. Baselt, R. C., Disposition of Toxic Drugs and Chemicals in Man, 5th ed., Chemical Toxicology Institute, Foster City, CA, 2000.
9. Perry, P. J. and Alexander, B., Switching haloperidol from oral to im depot formulation, DICP, Ann. Pharmacother., 25: 1270-1271, 1991.
10. Reyntgens, A. J. M. et al., Pharmacokinetics of haloperidol decanoate, Int. Pharmacopsychiatr., 17: 238-246, 1982.
11. Goren, J. L. and Levin, G. M., Quetiapine, an atypical antipsychotic, Pharmacotherapy, 18: 1183-1194, 1998.
12. DeVane, C. L. and Jarecke, C. R., Cyclic antidepressants, in Applied Pharmacokinetics, Principles of Therapeutic Drug Monitoring, Evans, W. E., Schentag, J. J., and Jusko, W. J., Eds., Applied Therapeutics, San Francisco, 1992, 1-34.
13. DeVane, C. L., Pharmacokinetics of the newer antidepressants, Am. J. Med., 97 (Suppl. 6A): 6A-13A, 1994.
14. Perry, P. J. et al., Two prospective dosing methods for nortriptyline, Clin. Pharmacokinet., 9: 555-563, 1991.
15. Perry, P. J., Alexander, B. and Liskow, B. I., Psychotropic Drug Handbook, American Psychiatric Press, Washington, D.C., 1997.
16. Perry, P. J. and Alexander, B., Dosage and serum levels, in Modern Lithium Therapy, Johnson, F. N., Ed., MTP Press, Lancaster, U.K., 1987, 70.